MedTrace Logo

L-carnitine for Fatigue in COPD

NCT03008356 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 33

Last updated 2019-01-23

No results posted yet for this study

Summary

supplementation with L-carnitine that is available both as an FDA-approved therapy for primary carnitine deficiency, as well as widely available as an over-the-counter ergogenic aid will improve wellbeing and function measured by questionnaires in patient with chronic obstructive pulmonary disease (COPD).

based on our review of literature that addition of health coaching (HC) to L-carnitine will yield greater gains.

Conditions

Interventions

DIETARY_SUPPLEMENT

L-carnitine 1000 mg twice daily

Oral L-carnitine to be taken twice daily for 8 weeks

BEHAVIORAL

Weekly health coaching calls

Weekly health coaching calls lasting 10-15 minutes

DIETARY_SUPPLEMENT

Placebo capsules

Sponsors & Collaborators

Principal Investigators

  • Roberto P Benzo · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-01-31
Primary Completion
2018-02-28
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03008356 on ClinicalTrials.gov